Back to Search
Start Over
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML – Commentary.
- Source :
-
Multiple Sclerosis Journal . May2017, Vol. 23 Issue 6, p770-771. 2p. - Publication Year :
- 2017
-
Abstract
- The article discusses a research related to high-frequency magnetic resonance imaging (MRI)monitoring to be performed in multiple sclerosis (MS) patients treated with natalizumab. It recommends need to analyze individual benefits while reducing risks of progressive multifocal leukoencephalopathy (PML) with natalizumab treatment in MS patients.
Details
- Language :
- English
- ISSN :
- 13524585
- Volume :
- 23
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Multiple Sclerosis Journal
- Publication Type :
- Academic Journal
- Accession number :
- 122805043
- Full Text :
- https://doi.org/10.1177/1352458516685170